Funder: Barth Syndrome Foundation
Due Dates: August 13, 2026 (Applications open) | October 30, 2026 (Full application, 11:59 PM EST) | March 2027 (Earliest notification and award start)
Funding Amounts: Up to US $100,000 total over 1–3 years, plus up to $25,000 for research-participant travel
Summary: Seed funding for basic, translational, and clinical research advancing understanding and treatment of Barth syndrome.
Key Information: Applicants must be independent investigators; predoctoral and postdoctoral fellows cannot apply.
Description
The Barth Syndrome Foundation (BSF) and its International Affiliates support innovative research addressing the basic, translational, and clinical challenges of Barth syndrome. The program provides seed funding to young and established independent investigators, helping generate preliminary data for subsequent support from major funders such as the National Institutes of Health. Eligible work includes basic research, discovery science, and early clinical studies related to Barth syndrome.
The program prioritizes projects that could significantly improve understanding of the disorder or its treatment, are feasible with the proposed investigators and resources, and offer credible prospects for long-term funding. Applications undergo competitive scientific peer review, with final funding decisions made by the BSF Board of Directors.
